[Episcleritis secondary to risedronate].
Viñas
Guillermina
G
Olivé
Alejandro
A
Holgado
Susana
S
Costa
Joan
J
D002121:Calcium Channel Blockers / Q000009:adverse effects*; D012968:Etidronic Acid / Q000009:adverse effects* / Q000031:analogs & derivatives*; D005260:Female; D006801:Humans; D008875:Middle Aged; D000068296:Risedronic Acid; D015423:Scleritis / Q000139:chemically induced*
D002121:Calcium Channel Blockers; D000068296:Risedronic Acid; D012968:Etidronic Acid